| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
5 companies
Eastham Karin serves as a Director at GERN and has filed Form 4s across 5 companies. Across recent SEC filings that breaks down to 0 buys and 46 sells. Those positions are worth an estimated $4.3M at current prices.
Historically, Eastham Karin's trades have earned a middling insider score of 65/100 across 16 rated trades. Over a 12-month horizon, 57.1% of those trades were profitable, with an average 12-month return of +7.2%.
The biggest single holding is ILMN (~$3.3M) as Director. The recent filings there lean toward selling, a net 6,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | VCYT Veracyte, Inc. | Director | Sell | 3,729 | $52.89 | $197,234.40 | -19.8% | -28.2% | - | |
| Dec 5, 2025 | VCYT Veracyte, Inc. | Director | Sale+OE | 20,000 | $45.45 | $908,923.34 | -59.6% | -22.3% | - | |
| Nov 5, 2025 | VCYT Veracyte, Inc. | Director | Sell | 9,674 | $40.02 | $387,191.21 | -41.6% | -18.0% | - | |
| Jun 13, 2025 | VCYT Veracyte, Inc. | Director | Sell | 4,590 | $26.66 | $122,387.76 | -24.8% | +20.5% | +79.0% | |
| Jan 2, 2025 | VCYT Veracyte, Inc. | Director | Sale+OE | 10,000 | $40.30 | $403,005.64 | -35.1% | -25.5% | +4.8% | |
| Nov 19, 2024 | VCYT Veracyte, Inc. | Director | Sell | 14,731 | $38.34 | $564,768.40 | -44.3% | +3.2% | +2.0% | |
| Jul 16, 2024 | VCYT Veracyte, Inc. | Director | Sell | 7,500 | $25.00 | $187,500.00 | -18.4% | +32.7% | -1.5% | |
| Jun 11, 2024 | VCYT Veracyte, Inc. | Director | Sell | 3,870 | $20.59 | $79,683.30 | -11.7% | +36.6% | +31.2% | |
| Jun 7, 2024 | VCYT Veracyte, Inc. | Director | Sale+OE | 2,500 | $20.97 | $52,425.00 | -7.0% | +44.2% | +33.0% | |
| Apr 1, 2024 | VCYT Veracyte, Inc. | Director | Sale+OE | 10,000 | $21.65 | $216,528.00 | -23.2% | -1.4% | +36.6% |